Accessibility Menu
 
AusCann Group logo

AusCann Group

(ASX) AC8

Current PriceN/A
Market CapN/A
Since IPO (2017)-82%
5 Year-90%
1 Year+0%
1 Month+0%

AusCann Group Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$967.98K

Net Income (TTM)

$21.66M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

AC8 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AusCann Group

Industry

Pharmaceuticals

CEO

Layton Patrick Mills

Headquarters

West Perth, WA 6005, AU

AC8 Financials

Key Financial Metrics (TTM)

Gross Margin

96%

Operating Margin

-1%

Net Income Margin

-10%

Return on Equity

-61%

Return on Capital

-19%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.06M

Operating Income

$1.38M

EBITDA

$2.68M

Operating Cash Flow

$3.33M

Capital Expenditure

$0.00

Free Cash Flow

$3.66M

Cash & ST Invst.

$7.30M

Total Debt

$0.00

AusCann Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$252.00

+99.9%

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

27

N/A

Net Income

$103.87K

+94.0%

EBITDA

$515.52K

+60.0%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Net Cash

$3.68M

-72.9%

Accounts Receivable

$170.00

-99.9%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.48%

N/A

Return on Invested Capital

-19.23%

N/A

Free Cash Flow

$627.76K

+44.4%

Operating Cash Flow

$627.76K

+44.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MXC.AXMGC Pharmaceuticals Limited
$0.42+2.44%
PXS.AXPharmaxis Ltd
$0.03+3.70%
IHL.AXIncannex Healthcare Limited
$0.04-10.87%
KZA.AXKazia Therapeutics Limited
$0.08+9.59%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%

Questions About AC8

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.